# US 2021/0233636 A1 · Pharmaceutical business method for high volume low risk sales with accelerated manufacturing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0233636 A1
- Document ID: US20210233636A1
- Status: Published application
- Kind: A1
- Application number: 17/207,636
- Filed: 2021-03-20
- Published: 2021-07-29
- Earliest claimed: 2014-06-17
- Inventors: David Brent Morgan
- Web page: https://patentgrep.com/patent/US20210233636A1

## CPC

- G06Q 30/06: Buying, selling or leasing transactions
- G06Q 10/04: Forecasting or optimisation specially adapted for administrative or management purposes, e.g. linear programming or "cutting stock problem" (market predictions or forecasting for commercial activities G06Q30/0202)
- G06Q 10/06315: {Needs-based resource requirements planning or analysis}
- G06Q 10/0635: Risk analysis of enterprise or organisation activities
- G06Q 10/087: Inventory or stock management, e.g. order filling, procurement or balancing against orders
- G06Q 20/401: {Transaction verification}
- G06Q 30/018: Certifying business or products
- G06Q 30/08: Auctions
- G16H 40/20: for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A business method for pharmaceutical sales in which additional parties or entities are introduced into the transaction such that simultaneous mass manufacturing and seeking regulatory approvals for the sales of pharmaceutical is feasible. The method promotes the early widespread adoption and use of pharmaceuticals while reducing risk and increasing sales volume through guaranteed advance bulk purchase agreements. The resulting method achieves speed to mass markets heretofore not realized.

## Claims

### Claim 1

A computerized software analysis method for high volume low risk pharmaceutical sales with accelerated manufacturing; wherein mass pharmaceutical manufacturing and seeking regulatory approval occur in parallel.

### Claim 2 (depends on 1)

The method as claimed in claim 1 wherein additional parties or entities negotiate an advance bulk purchase agreement.

### Claim 3 (depends on 2)

The method as claimed in claim 2 wherein an advance bulk purchase agreement is successfully negotiated by said one or more additional parties or entities.

### Claim 4 (depends on 3)

The method as claimed in claim 3 wherein the said bulk purchase agreement is enacted.
